C World Wide Group Holding A Vaxcyte, Inc. Transaction History
C World Wide Group Holding A
- $8.06 Billion
- Q1 2025
A detailed history of C World Wide Group Holding A transactions in Vaxcyte, Inc. stock. As of the latest transaction made, C World Wide Group Holding A holds 95,000 shares of PCVX stock, worth $3.26 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
95,000Holding current value
$3.26 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
353Shares Held
126MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$410 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$363 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$341 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$298 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$213 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.03B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...